Thursday, August 26, 2010 7:57:30 PM
As Rob said in the 7-14-10 CC:
“We’ve been working equally hard I think on the Biosimilars program and really have made an astonishing amount of progress in an area, which as you can imagine is quite convoluted and difficult. I think we’re nearing our final decisions as to which candidates to bring forward, and really probably our next step will be to solidify our final decision, and then begin discussions with the FDA about how to proceed forward with this program because as you know, the FDA now has under the Patient Protection Health Care Act that was signed into law in March, and that was a pathway for biosimilars in the U.S. and we plan to take full advantage of that pathway as soon as possible. So, a very exciting project actually.”
http://tinyurl.com/3a4p66c
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
